GUILLAIN-BARRE-SYNDROME FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION

We describe four patients who developed Guillain-Barre syndrome (GBS) following allogeneic bone marrow transplantation (BMT). All four patie nts had a febrile illness before developing GBS. Two patients had mild graft-versus-host disease but did not require immunosuppression. Thes e patients add to the increasing number of BMT patients whose courses have been complicated by GBS and raise the possibility that BMT patien ts, especially those undergoing allogeneic BMT, may have a higher risk of developing GBS.